| Darunavir Viatris 400 mg film-coated tablets EU/1/16/1140/022-029 |
Darunavir |
Viatris Limited |
— |
| Darunavir Viatris 600mg film-coated tablets EU/1/16/1140/030-038 |
Darunavir |
Viatris Limited |
— |
| Darunavir Viatris 75 mg film-coated tablets EU/1/16/1140/001-005 |
Darunavir |
Viatris Limited |
— |
| Darunavir Viatris 800 mg film-coated tablets EU/1/16/1140/039-045 |
Darunavir |
Viatris Limited |
— |
| DARZALEX 1800 mg solution for injection EU/1/16/1101/004 |
Daratumumab |
Janssen-Cilag International NV |
— |
| DARZALEX 20 mg/mL concentrate for solution for infusion EU/1/16/1101/001-003 |
Daratumumab |
Janssen-Cilag International NV |
— |
| Dasatinib Accord Healthcare 100 mg film-coated tablets EU/1/24/1839/017-020 |
Dasatinib |
Accord Healthcare S.L.U. |
— |
| Dasatinib Accord Healthcare 140 mg film-coated tablets EU/1/24/1839/021-024 |
Dasatinib |
Accord Healthcare S.L.U. |
— |
| Dasatinib Accord Healthcare 20 mg film-coated tablets EU/1/24/1839/001-004 |
Dasatinib |
Accord Healthcare S.L.U. |
— |
| Dasatinib Accord Healthcare 50 mg film-coated tablet EU/1/24/1839/005-008 |
Dasatinib |
Accord Healthcare S.L.U. |
— |
| Dasatinib Accord Healthcare 70 mg film-coated tablets EU/1/24/1839/009-012 |
Dasatinib |
Accord Healthcare S.L.U. |
— |
| Dasatinib Accord Healthcare 80 mg film-coated tablets EU/1/24/1839/013-016 |
Dasatinib |
Accord Healthcare S.L.U. |
— |
| Dasatinib Clonmel 100 mg film-coated tablets PA0126/310/004 |
Dasatinib |
Clonmel Healthcare Ltd |
Marketed |
| Dasatinib Clonmel 20 mg film-coated tablets PA0126/310/001 |
Dasatinib |
Clonmel Healthcare Ltd |
Marketed |
| Dasatinib Clonmel 50 mg film-coated tablets PA0126/310/002 |
Dasatinib |
Clonmel Healthcare Ltd |
Marketed |
| Dasatinib Clonmel 70 mg film-coated tablets PA0126/310/003 |
Dasatinib |
Clonmel Healthcare Ltd |
Marketed |
| Dasatinib Krka 100 mg film-coated tablets PA1347/093/005 |
Dasatinib |
KRKA, d.d., Novo mesto |
Not marketed |
| Dasatinib Krka 140 mg film-coated tablets PA1347/093/006 |
Dasatinib |
KRKA, d.d., Novo mesto |
Not marketed |
| Dasatinib Krka 20 mg film-coated tablets PA1347/093/001 |
Dasatinib |
KRKA, d.d., Novo mesto |
Not marketed |
| Dasatinib Krka 50 mg film-coated tablets PA1347/093/002 |
Dasatinib |
KRKA, d.d., Novo mesto |
Not marketed |
| Dasatinib Krka 70 mg film-coated tablets PA1347/093/003 |
Dasatinib |
KRKA, d.d., Novo mesto |
Not marketed |
| Dasatinib Krka 80 mg film-coated tablets PA1347/093/004 |
Dasatinib |
KRKA, d.d., Novo mesto |
Not marketed |
| Dasatinib Teva 100 mg Film-coated Tablets PA1986/066/004 |
Dasatinib |
Teva B.V. |
Marketed |
| Dasatinib Teva 20 mg Film-coated Tablets PA1986/066/001 |
Dasatinib |
Teva B.V. |
Marketed |
| Dasatinib Teva 50 mg Film-coated Tablets PA1986/066/002 |
Dasatinib |
Teva B.V. |
Marketed |
| Dasatinib Teva 70 mg Film-coated Tablets PA1986/066/003 |
Dasatinib |
Teva B.V. |
Marketed |
| Dasselta 5 mg film-coated tablets EU/1/11/739/001-008 |
Desloratadine |
KRKA, d.d., Novo mesto |
— |
| Datroway 100 mg powder for concentrate for solution for infusion EU/1/25/1915/001 |
Datopotamab deruxtecan |
Daiichi Sankyo Europe GmbH |
— |
| DaTSCAN 74 MBq/ml solution for injection EU/1/00/135/001-002 |
Ioflupane |
GE Healthcare B.V. |
— |
| Daurismo 100 mg film-coated tablets EU/1/20/1451/003-004 |
Glasdegib Maleate |
Pfizer Europe MA EEIG |
— |
| Daurismo 25 mg film-coated tablets EU/1/20/1451/001-002 |
Glasdegib Maleate |
Pfizer Europe MA EEIG |
— |
| Dawnzera 80mg solution for injection in pre-filled pen EU/1/25/2001/001-002 |
Donidalorsen sodium |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Daxas 250 micrograms tablets EU/1/10/636/008 |
Roflumilast |
AstraZeneca AB |
— |
| Daxas 500 micrograms film-coated tablets EU/1/10/636/001-007 |
Roflumilast |
AstraZeneca AB |
— |
| Dazublys 150 mg powder for concentrate for solution for infusion EU/1/25/1949/001 |
Trastuzumab |
Curateq Biologics s.r.o. |
— |
| DDAVP/Desmopressin 4 micrograms/ml Solution for Injection PA1009/001/002 |
DESMOPRESSIN ACETATE |
Ferring Ireland Ltd |
Marketed |
| Decapeptyl 3-month, 11.25 mg powder and solvent for suspension for injection PPA0465/261/001 |
Triptorelin |
PCO Manufacturing Ltd. |
— |
| Decapeptyl 3-month, 11.25 mg powder and solvent for suspension for injection PPA1463/126/001 |
Triptorelin |
IMED Healthcare Ltd., |
— |
| Decapeptyl 3-month, 11.25 mg Powder and solvent for suspension for injection PPA2306/022/001 |
Triptorelin |
Originalis B.V. |
— |
| Decapeptyl 3-month, 11.25 mgPowder and solvent for suspension for injection PA0869/003/002 |
Triptorelin |
Ipsen Pharmaceuticals Limited |
Marketed |
| Decapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection PA0869/003/003 |
Triptorelin pamoate |
Ipsen Pharmaceuticals Limited |
Marketed |
| Decapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection PPA0465/261/002 |
Triptorelin pamoate |
PCO Manufacturing Ltd. |
— |
| Decapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection PPA1463/126/002 |
Triptorelin |
IMED Healthcare Ltd., |
— |
| Decapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection PPA25370/003/001 |
Triptorelin pamoate |
BModesto B.V. |
— |
| Decapeptyl SR, 3 mg powder and solvent for suspension for injection PA0869/003/001 |
Triptorelin |
Ipsen Pharmaceuticals Limited |
Marketed |
| Decitabine Accord 40 mg powder for concentrate for solution for infusion PA2315/282/001 |
Decitabine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Decitabine Accord 50 mg powder for concentrate for solution for infusion PA2315/282/002 |
Decitabine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Decitabine EVER Pharma 50 mg powder for concentrate for solution for infusion PA1774/011/001 |
Decitabine |
EVER Valinject GmbH |
Not marketed |
| Dectova 10 mg/mL solution for infusion EU/1/18/1349/001 |
Zanamivir |
GlaxoSmithKline Trading Services Limited |
— |
| Deferasirox Accord 180 mg film-coated tablets EU/1/19/1412/005-008 |
Deferasirox |
Accord Healthcare S.L.U. |
— |